Prognostic value of geriatric assessment in older patients with advanced breast cancer receiving chemotherapy

Breast

Volumn 22, Issue 5, 2013, Pages 753-760

  Aaldriks, A A ^a   Giltay, E J ^b   le Cessie, S ^b   van der Geest, L G M ^c   Portielje, J E A ^d   Tanis, B C ^e   Nortier, J W R ^b   Maartense, E ^f  

^a Bouman Geestelijke Gezondheidszorg   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Department of Registration and Research   (Netherlands)

^d HAGA HOSPITAL   (Netherlands)

^e GROENE HART HOSPITAL   (Netherlands)

^f REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

Breast cancer; Chemotherapy; Elderly; Geriatric assessment

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CREATININE; HEMOGLOBIN; LACTATE DEHYDROGENASE; TRASTUZUMAB;

ADVANCED CANCER; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FRAIL ELDERLY; GERIATRIC ASSESSMENT; GERIATRIC NUTRITION; GRONINGEN FRAILTY INDICATOR; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFORMANT QUESTIONNAIRE ON COGNITIVE DECLINE IN THE ELDERLY; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MINI MENTAL STATE EXAMINATION; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM;

BREAST CANCER; CHEMOTHERAPY; ELDERLY; GERIATRIC ASSESSMENT;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; COGNITION DISORDERS; CREATININE; FEMALE; GERIATRIC ASSESSMENT; HEMOGLOBINS; HUMANS; KAPLAN-MEIER ESTIMATE; L-LACTATE DEHYDROGENASE; MALE; MALNUTRITION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SERUM ALBUMIN;

EID: 84884152861     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.01.011     Document Type: Article

References (41)

1. DeSantis C., Siegel R., Bandi P., Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin 2011, 61(6):409-418.
2. Extermann M., Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 2007, 25(14):1824-1831.
3. Extermann M., Overcash J., Lyman G. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998, 16:1582-1587.
4. Repetto L., Fratino L., Audisio R.A., Venturino A., Gianni W., Vercelli M., et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002, 20(2):494-502.
5. Balducci L., Yates J. General guidelines for the management of older patients with cancer. Oncology (Williston Park) 2000, 14(11A):221-227.
6. Barthelemy P., Heitz D., Mathelin C., Polesi H., Asmane I., Litique V., et al. Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals. Crit Rev Oncol Hematol 2010, 79(2):196-204.
7. Pentheroudakis G., Fountzilas G., Kalofonos H.P., Golfinopoulos V., Aravantinos G., Bafaloukos D., et al. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors. Crit Rev Oncol Hematol 2008, 66(3):237-247.
8. Clough-Gorr K.M., Stuck A.E., Thwin S.S., Silliman R.A. Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up. J Clin Oncol 2009, 28(3):380-386.
9. Extermann M., Chen H., Cantor A.B., Corcoran M.B., Meyer J., Grendys E., et al. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer 2002, 38(11):1466-1473.
10. Hurria A., Cirrincione C.T., Muss H.B., Kornblith A.B., Barry W., Artz A.S., et al. Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401. J Clin Oncol 2011, 29(10):1290-1296.
11. Dewys W.D., Begg C., Lavin P.T., Band P.R., Bennett J.M., Bertino J.R., et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980, 69(4):491-497.
12. Soubeyran P., Fonck M., Blanc-Bisson C., Blanc J.F., Ceccaldi J., Mertens C., et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 2012, 30(15):1829-1834.
13. Ahles T.A., Root J.C., Ryan E.L. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol 2012, 30(30):3675-3686.
14. Jim H.S., Phillips K.M., Chait S., Faul L.A., Popa M.A., Lee Y.H., et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol 2012, 30(29):3578-3587.
15. Rodin G., Ahles T.A. Accumulating evidence for the effect of chemotherapy on cognition. J Clin Oncol 2012, 30(29):3568-3569.
16. Heppner H.J., Bauer J.M., Sieber C.C., Bertsch T. Laboratory aspects relating to the detection and prevention of frailty. Int J Prev Med 2010, 1(3):149-157.
17. Kuzuya M., Izawa S., Enoki H., Okada K., Iguchi A. Is serum albumin a good marker for malnutrition in the physically impaired elderly?. Clin Nutr 2007, 26(1):84-90.
18. Artz A.S. Anemia and the frail elderly. Semin Hematol 2008, 45(4):261-266.
19. den Elzen W.P., Willems J.M., Westendorp R.G., de Craen A.J., Assendelft W.J., Gussekloo J. Effect of anemia and comorbidity on functional status and mortality in old age: results from the Leiden 85-plus Study. CMAJ 2009, 181(3-4):151-157.
20. Penninx B.W., Pahor M., Cesari M., Corsi A.M., Woodman R.C., Bandinelli S., et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 2004, 52(5):719-724.
21. Molina-Garrido M.J., Guillen-Ponce C. Development of a cancer-specific Comprehensive Geriatric Assessment in a University Hospital in Spain. Crit Rev Oncol Hematol 2011, 77(2):148-161.
22. Guigoz Y., Vellas B. The Mini Nutritional Assessment (MNA) for grading the nutritional state of elderly patients: presentation of the MNA, history and validation. Nestle Nutr Workshop Ser Clin Perform Programme 1999, 1(3-11):11-12. discussion.
23. Slaets J.P. Vulnerability in the elderly: frailty. Med Clin North Am 2006, 90(4):593-601.
24. Jorm A.F., Jacomb P.A. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989, 19(4):1015-1022.
25. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12(3):189-198.
26. Aaldriks A.A., Maartense E., le Cessie S., Giltay E.J., Verlaan H.A., van der Geest L.G., et al. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol 2011, 79(2):205-212.
27. Toliusiene J., Lesauskaite V. The nutritional status of older men with advanced prostate cancer and factors affecting it. Support Care Cancer 2004, 12(10):716-719.
28. Vellas B., Guigoz Y., Garry P.J., Nourhashemi F., Bennahum D., Lauque S., et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999, 15(2):116-122.
29. de Jonghe J.F. Differentiating between demented and psychiatric patients with the Dutch version of the IQCODE. Int J Geriatr Psychiatry 1997, 12(4):462-465.
30. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
31. Karnofsky D.A., Burchenal J.H. The Clinical Evaluation of Chemotherapeutic Agents in Cancer. Evaluation of Chemotherapeutic Agents 1949, 196. Columbia Univ Press. C.M. MacLeod (Ed.).
32. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5(6):649-655.
33. Guigoz Y., Lauque S., Vellas B.J. Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med 2002, 18(4):737-757.
34. Kanesvaran R., Li H., Koo K.N., Poon D. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol 2011, 29(27):3620-3627.
35. Hamaker M.E., Jonker J.M., de Rooij S.E., Vos A.G., Smorenburg C.H., van Munster B.C. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol 2012, 13(10):e437-e444.
36. Kellen E., Bulens P., Deckx L., Schouten H., Van Dijk M., Verdonck I., et al. Identifying an accurate pre-screening tool in geriatric oncology. Crit Rev Oncol Hematol 2010, 75(3):243-248.
37. Hurria A., Rosen C., Hudis C., Zuckerman E., Panageas K.S., Lachs M.S., et al. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 2006, 54(6):925-931.
38. Extermann M., Boler I., Reich R.R., Lyman G.H., Brown R.H., DeFelice J., et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2011, 118(13):3377-3386.
39. Hurria A., Togawa K., Mohile S.G., Owusu C., Klepin H.D., Gross C.P., et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011, 29(25):3457-3465.
40. Emanuel E.J., Young-Xu Y., Levinsky N.G., Gazelle G., Saynina O., Ash A.S. Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med 2003, 138(8):639-643.
41. Cardoso F., Costa A., Norton L., Cameron D., Cufer T., Fallowfield L., et al. 1st International consensus guidelines for advanced breast cancer (ABC 1). Breast 2012, 21(3):242-252.